Honey is roughly 80% sugar by weight, mostly fructose and glucose, so on paper it looks like it should fuel cancer cells the same way a spoonful of table sugar would. The reality is more complicated. While any caloric sweetener raises blood glucose and can theoretically supply energy to tumors, honey carries a package of bioactive compounds that, in laboratory and animal studies, appear to work against several cancer-promoting processes. No one has proven that swapping sugar for honey prevents or treats cancer in humans, but the two sweeteners are not metabolically identical, and the differences matter more than most people assume.
What Cancer Cells Actually Do With Sugar
Cancer cells are notorious for burning through glucose at a far higher rate than normal cells. This metabolic quirk, sometimes called aerobic glycolysis, means tumors preferentially pull glucose from the bloodstream to fuel rapid growth. That basic fact is what drives the popular idea that “sugar feeds cancer.” It is not wrong as a general statement: glucose is the primary fuel for most tumors, and higher blood sugar gives them more to work with.
But the leap from “cancer cells use glucose” to “any food containing sugar is equally dangerous” skips over important details. How fast a food raises your blood sugar, how high that spike goes, what else the food delivers alongside the sugar, and how your body processes the specific sugars involved all influence what happens downstream. A food that produces a smaller blood-sugar spike, provokes a lower insulin response, and delivers compounds that interfere with tumor-growth pathways is not equivalent to one that does the opposite, even if both contain roughly the same grams of sugar.
Honey’s Glycemic Behavior Compared to Table Sugar
One of the clearest differences between honey and refined sugar is how they affect blood glucose after you eat them. Table sugar (sucrose) splits into equal parts glucose and fructose during digestion. Honey also contains glucose and fructose, but in different ratios that vary by floral source, and it includes small amounts of oligosaccharides, organic acids, and other compounds that slow absorption.
In a study of Jordanian honeys, healthy volunteers who consumed honey showed lower glycemic index values compared to those who consumed sucrose. Two varieties, Christ thorn honey and sugar honey, had glycemic index values around 45 and 51 respectively, while sucrose landed at about 114. Even in volunteers with type 2 diabetes, all tested honeys produced lower glycemic responses than sucrose, though the gap was smaller.1Pakistan Journal of Nutrition. Glycemic and Insulinemic Response of Different Types of Jordanian Honey in Healthy and Type 2 Diabetic Volunteers A separate analysis of German honey varieties found that five of eight tested honeys qualified as low-glycemic (below 55), and the glycemic response correlated with fructose content: higher-fructose honeys tended to produce lower blood-sugar spikes.2European Journal of Clinical Nutrition. Glycaemic and insulinaemic properties of some German honey varieties
Why does this matter for cancer? Higher dietary glycemic load has been linked to increased cancer risk in observational research. In a large prospective study of Italian women, those with the highest dietary glycemic load had roughly two and a half times the breast cancer risk of women with the lowest glycemic load after adjustments for fat and fiber intake.3The American Journal of Clinical Nutrition. Dietary glycemic index, glycemic load, and breast cancer risk in a prospective cohort study of Italian women No study has directly tested whether substituting honey for sugar lowers cancer incidence, but the logic runs in a consistent direction: if chronic high-glycemic eating raises risk, a lower-glycemic sweetener is at least theoretically less harmful.
The Fructose Wrinkle
Honey’s lower glycemic index is partly explained by its high fructose content, since fructose does not raise blood glucose as sharply as glucose does. But fructose is not innocent in the cancer story. Some tumor types have found ways to use fructose directly.
Research on lung cancer tissue found that a fructose transporter called GLUT5 was significantly upregulated in tumor cells compared to normal lung tissue, allowing those tumors to pull in fructose and use it to drive fatty acid production and growth-signaling pathways.4The Journal of Clinical Investigation. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling GLUT5 has also been identified as a potential therapeutic target in breast cancer cells, where blocking fructose uptake reduced cancer cell activity in lab experiments.5PubMed Central. Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation In colorectal cancer, fructose metabolism through the GLUT5-KHK axis has been shown to fuel tumor growth and even promote chemotherapy resistance.6PubMed. GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer A separate study found that fructose absorbed by primary colorectal tumors could accelerate liver metastasis through a specific enzyme pathway.7PubMed Central. KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2
This is worth keeping in perspective. The fructose research involves isolated cancer cells, genetically engineered mice, and tissue analysis, not people eating honey. And the amounts of fructose consumed in a typical serving of honey (a tablespoon contains around 8 to 9 grams of fructose) are far smaller than the doses used in most experimental setups. The concern about fructose and cancer is real and growing, but it applies primarily to high-fructose diets in general, not to honey specifically. A can of soda delivers more fructose than most people put on their toast.
What Honey Delivers Beyond Sugar
The part of honey that makes it genuinely different from table sugar or corn syrup is the roughly 5% that is not sugar or water. That fraction contains polyphenols, flavonoids, organic acids, enzymes, and trace minerals, and the composition varies dramatically by floral source. Italian Millefiori honeys, for instance, had phenolic content ranging from about 12.5 to 17.5 milligrams per 100 grams, while acacia honeys from the same region had roughly 3 to 11 milligrams per 100 grams.8Food Chemistry. Raw Millefiori honey is packed full of antioxidants Different botanical origins produce different dominant compounds: hesperetin in citrus honey, kaempferol and chrysin in rosemary honey, quercetin and p-coumaric acid in honeydew honey.9Food Chemistry. Suitability of antioxidant capacity, flavonoids and phenolic acids for floral authentication of honey. Impact of industrial thermal treatment
Many of these polyphenols have been studied individually for anti-cancer effects, and when they are delivered together in honey, a growing body of lab research suggests they can interfere with tumor biology at multiple points: slowing cell division, triggering programmed cell death in cancer cells, reducing inflammation, and dampening the blood-vessel growth that tumors need to expand.10PubMed Central. Honey and Cancer: Current Status and Future Directions A review of in vitro studies across various cancer cell types found that honey’s polyphenols were largely responsible for these antiproliferative effects, and that honey used alongside chemotherapy drugs sometimes enhanced the drugs’ ability to kill cancer cells while reducing side effects.11PubMed Central. From Chemical Composition to Antiproliferative Effects Through In Vitro Studies: Honey, an Ancient and Modern Hot Topic Remedy
Animal Evidence for Anti-Tumor Effects
The most striking evidence that honey does not simply “feed” cancer comes from animal experiments. In a study using rats with chemically induced breast tumors, animals treated with Tualang honey developed tumors more slowly, with lower incidence and smaller tumor masses compared to untreated controls. Tumor progression took a mean of about 75 days in the honey-treated group versus 52 days in controls, tumor incidence dropped from 100% to about 77%, and the average tumor weight was roughly a third of what it was in untreated animals. Histological grading also showed less aggressive tumors in the honey group.12PubMed Central. The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: an experimental animal study
These are animal results and cannot be translated directly to humans. But they undercut the idea that honey’s sugar content overwhelms its other properties. If honey simply fed tumors the way refined sugar does, you would expect the honey-treated animals to do worse, not better. The fact that they did better suggests the bioactive compounds in honey have effects that outweigh, at least in this context, the sugar load.
The Insulin and Growth Factor Connection
One of the ways sugar may promote cancer growth is indirect: through insulin and insulin-like growth factors. When you eat high-glycemic foods, your pancreas releases more insulin to manage the blood-sugar spike. Chronically elevated insulin can raise levels of insulin-like growth factor 1 (IGF-1), which is linked to cell proliferation, resistance to cell death, and tumor development. High serum concentrations of IGF-1 have been associated with increased risk of breast, prostate, colorectal, and lung cancers.13PubMed. Insulin-like growth factors and cancer The IGF system promotes not just cell growth but also blood vessel formation and metastatic activity across multiple cancer types.14PubMed Central. Insulin-like growth factor system in cancer: novel targeted therapies
Because honey tends to produce a smaller insulin spike than equivalent amounts of table sugar, it may be somewhat less likely to drive this hormonal cascade. “Somewhat” is the right word here. Honey still raises blood sugar and still triggers insulin release. Eating large quantities would still push your metabolic system in the wrong direction. The advantage is relative, not absolute.
Honey’s Antioxidant Properties and Oxidative Stress
Chronic oxidative stress, an imbalance where damaging reactive molecules overwhelm the body’s defenses, contributes to DNA damage that can initiate and promote cancer. Honey’s polyphenol content gives it measurable antioxidant activity, and this has been tested in living animals. Manuka honey supplementation in middle-aged rats reduced markers of DNA damage in the liver and lowered malondialdehyde levels, a common marker of oxidative damage. It also increased the antioxidant enzyme glutathione peroxidase in red blood cells of the middle-aged group.15Clinics. Manuka honey protects middle-aged rats from oxidative damage
Again, these are animal data, and the amounts of honey used in research do not always correspond to reasonable human servings. But the consistent direction of the findings, less oxidative damage, less DNA injury, supports the idea that honey delivers something biochemically meaningful beyond its calories.
How Processing Changes the Equation
Not all honey on store shelves is the same product. Industrial processing, specifically the heat treatment used to pasteurize honey and prevent crystallization, can degrade the very compounds that distinguish honey from plain sugar water. Pasteurization at 78°C reduced enzymatic activity by about 15.5%, and storage of heat-treated honey further diminished antioxidant properties over time.16PubMed Central. The High Pressure Preservation of Honey: A Comparative Study on Quality Changes during Storage Even milder heat treatments (30 minutes at 63°C) significantly reduced total phenolic content across multiple honey types, with decreases that could meaningfully affect the health value of the product.17PubMed Central. Effect of thermal treatment on physicochemical and antioxidant properties of honey
If you are choosing honey partly for its bioactive compounds, this matters. The clear, syrupy honey in a squeeze bear at the grocery store has often been heated and ultra-filtered, which strips out pollen and degrades polyphenols. Raw, minimally processed honey retains more of its original chemistry. This does not make processed honey dangerous, but it does make it closer to ordinary sugar in its overall metabolic profile.
Honey in Active Cancer Treatment
Oncologists and nurses already use honey in certain cancer-care settings, though not as a cancer treatment per se. One of the most studied applications is managing oral mucositis, the painful mouth sores that develop during radiation therapy for head and neck cancers. A systematic review found that honey significantly reduced the occurrence of severe (grade 3-4) mucositis, provided pain relief, and helped limit weight loss during treatment.18PubMed Central. Honey in Alleviating Severe Oral Mucositis Among Head and Neck Cancer Patients Undergoing Radiation Therapy A randomized trial evaluating this found that honey-treated patients had significantly lower pain scores throughout radiation therapy and fewer treatment gaps, which is important because interruptions in radiation can reduce its effectiveness.19PubMed Central. A Randomized Controlled Trial Evaluating the Role of Honey in Reducing Pain Due to Radiation Induced Mucositis in Head and Neck Cancer Patients
The evidence is not uniformly positive, though. A placebo-controlled trial of manuka honey specifically for radiation-induced oral mucositis found that it was not well tolerated by patients and did not significantly reduce mucositis severity.20PubMed. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis This inconsistency highlights a recurring theme: the type of honey, the dose, and the specific clinical situation all influence outcomes.
Beyond mucositis, medical-grade honey has been used for wound care in pediatric oncology patients, where its antibacterial properties proved effective against drug-resistant bacteria commonly found in hospital-acquired infections.21PubMed. Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology A systematic review of honey in oncology care identified applications including radiation-induced skin reactions, hand-and-foot syndrome from chemotherapy, and surgical wound healing.22PubMed. A systematic review of honey uses and its potential value within oncology care Manuka honey in particular has demonstrated broad-spectrum antimicrobial properties and the ability to support tissue regeneration through its unique chemical profile.23PubMed Central. Clinical and Postoperative Applications of Manuka Honey in Wound Healing: An Evidence-Based Review
Honey Combined With Chemotherapy Drugs
Some of the most intriguing lab findings involve honey used alongside standard cancer drugs. In colon cancer cell lines, strawberry tree honey combined with the chemotherapy drug 5-fluorouracil reduced cell viability and increased oxidative stress in cancer cells more effectively than the drug alone.24PubMed. Strawberry tree honey in combination with 5-fluorouracil enhances chemosensitivity in human colon adenocarcinoma cells Reviews of manuka honey research have also noted evidence that it can increase the efficiency of chemotherapy drugs while protecting the body from some of their side effects.25PharmaNutrition. The healing power of Manuka honey: A comprehensive review of its anti-cancer properties
These are cell-culture and review-level findings, not results from clinical trials in cancer patients. The gap between showing something works in a petri dish and proving it works in a person is enormous. But the direction of the evidence is consistent enough that researchers have argued honey deserves serious investigation as a low-cost adjunct therapy, particularly in resource-limited settings where expensive supportive-care drugs are unavailable.26PubMed Central. Honey and cancer: sustainable inverse relationship particularly for developing nations-a review
What This Means for Your Diet
If you are healthy and wondering whether to use honey instead of sugar, the honest answer is that a tablespoon of honey is not going to cause or prevent cancer. The amounts involved in normal dietary use are small, and no human trial has shown that switching sweeteners changes cancer outcomes. What the evidence does suggest is that honey is not metabolically interchangeable with table sugar. It produces a lower glycemic response, delivers bioactive compounds with demonstrated anti-inflammatory and antioxidant properties, and, in experimental settings, works against rather than in favor of tumor growth.
If you are undergoing cancer treatment, talk to your oncology team before making dietary changes based on laboratory research. The supportive-care uses of honey, for mouth sores and wound healing, have reasonable clinical backing, but those applications typically use medical-grade products under clinical supervision, not the jar from your pantry. And regardless of the sweetener you choose, keeping overall sugar intake moderate is the dietary strategy with the strongest evidence behind it. The question is less about honey versus sugar and more about how much sweetness of any kind you are consuming across your whole diet.
Choosing Honey If the Bioactive Compounds Matter to You
For people who want to maximize whatever benefit honey’s non-sugar compounds can offer, a few practical points are worth knowing. Darker honeys, like buckwheat, manuka, and honeydew varieties, generally contain higher concentrations of polyphenols and flavonoids than lighter honeys such as acacia. Raw or minimally filtered honey retains more of its original enzyme and phenolic content than commercially pasteurized products. Heat degrades some of these compounds, so adding honey to boiling tea or using it in baking at high temperatures will reduce the bioactive fraction, though it will not eliminate it entirely. And the dose still matters: honey is roughly 80% sugar by weight, so eating large quantities to “get more antioxidants” would undermine the point by flooding your system with sugar you do not need.